Thermo Fisher Scientific Inc. (TMO)

Basic

  • Market Cap

    $189.37B

  • EV

    $218.79B

  • Shares Out

    386.37M

  • Revenue

    $43.42B

  • Employees

    130,000

Margins

  • Gross

    39.96%

  • EBITDA

    24.97%

  • Operating

    17.1%

  • Pre-Tax

    14.39%

  • Net

    13.68%

  • FCF

    15.08%

Returns (5Yr Avg)

  • ROA

    6.01%

  • ROE

    16.13%

  • ROCE

    11.11%

  • ROIC

    10.12%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $531.22

  • P/E

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • EV/FCF

    —

Per Share

  • Rev

    $112.05

  • Earnings (Dil)

    $15.26

  • FCF

    $16.84

  • Book Value

    $117.32

Growth (CAGR)

  • Rev 3Yr

    15.07%

  • Rev 5Yr

    12.69%

  • Rev 10Yr

    12.92%

  • Dil EPS 3Yr

    7.76%

  • Dil EPS 5Yr

    19.19%

  • Dil EPS 10Yr

    15.43%

  • Rev Fwd 2Yr

    -2.14%

  • EBITDA Fwd 2Yr

    -4.51%

  • EPS Fwd 2Yr

    -2.19%

  • EPS LT Growth Est

    10.27%

Dividends

  • Yield

    —

  • Payout

    8.81%

  • DPS

    $1.35

  • DPS Growth 3Yr

    16.67%

  • DPS Growth 5Yr

    15.39%

  • DPS Growth 10Yr

    8.45%

  • DPS Growth Fwd 2Yr

    9.52%

Select a metric from the list below to chart it

Dec '13
Dec '15
Dec '17
Dec '19
Dec '21
LTM
Metric
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
LTM

Total Revenues

24,358.0

25,542.0

32,218.0

39,211.0

44,915.0

43,421.0

Total Revenues % Chg.

16.4%

4.9%

26.1%

21.7%

14.5%

-1.7%

Cost of Goods Sold, Total

13,489.0

14,214.0

16,214.0

19,573.0

25,917.0

26,071.0

Gross Profit

10,869.0

11,328.0

16,004.0

19,638.0

18,998.0

17,350.0

Selling General & Admin Expenses, Total

6,022.0

6,139.0

6,940.0

7,857.0

8,940.0

8,523.0

R&D Expenses

967.0

1,003.0

1,181.0

1,406.0

1,471.0

1,401.0

Other Operating Expenses

—

—

16.0

3.0

—

—

Other Operating Expenses, Total

6,989.0

7,142.0

8,137.0

9,266.0

10,411.0

9,924.0

Operating Income

3,880.0

4,186.0

7,867.0

10,372.0

8,587.0

7,426.0

Interest Expense, Total

-667.0

-676.0

-553.0

-536.0

-726.0

-1,254.0

Interest And Investment Income

137.0

224.0

65.0

43.0

272.0

720.0

Net Interest Expenses

-530.0

-452.0

-488.0

-493.0

-454.0

-534.0

Income (Loss) On Equity Invest.

—

—

-3.0

-4.0

-172.0

-88.0

Currency Exchange Gains (Loss)

—

—

—

162.0

102.0

62.0

Other Non Operating Income (Expenses)

21.0

65.0

5.0

-161.0

-35.0

-17.0

EBT, Excl. Unusual Items

3,371.0

3,799.0

7,381.0

9,876.0

8,028.0

6,849.0

Restructuring Charges

-52.0

-52.0

-51.0

-37.0

-95.0

-415.0

Merger & Related Restructuring Charges

-48.0

—

-81.0

-35.0

—

—

Gain (Loss) On Sale Of Investments

-15.0

44.0

10.0

66.0

-161.0

-58.0

Gain (Loss) On Sale Of Assets

6.0

482.0

—

—

14.0

22.0

Asset Writedown

—

—

-32.0

-122.0

-60.0

-60.0

Legal Settlements

46.0

—

—

—

—

-18.0

Other Unusual Items

-46.0

-201.0

—

-911.0

-63.0

-73.0

EBT, Incl. Unusual Items

3,262.0

4,072.0

7,227.0

8,837.0

7,663.0

6,247.0

Income Tax Expense

324.0

374.0

850.0

1,109.0

703.0

324.0

Earnings From Continuing Operations

2,938.0

3,698.0

6,377.0

7,728.0

6,960.0

5,923.0

Earnings Of Discontinued Operations

—

—

—

—

—

—

Minority Interest

—

-2.0

-2.0

-3.0

-10.0

18.0

Net Income

2,938.0

3,696.0

6,375.0

7,725.0

6,950.0

5,941.0

Net Income to Common Incl Extra Items

2,938.0

3,696.0

6,375.0

7,725.0

6,950.0

5,941.0

Net Income to Common Excl. Extra Items

2,938.0

3,696.0

6,375.0

7,725.0

6,950.0

5,941.0

Total Shares Outstanding

402.1

398.7

396.7

394.4

390.5

386.4

Weighted Avg. Shares Outstanding

402.0

400.0

396.0

394.0

392.0

387.5

Weighted Avg. Shares Outstanding Dil

406.0

403.0

399.0

397.0

394.0

388.8

EPS

7.3

9.2

16.1

19.6

17.7

15.3

EPS Diluted

7.2

9.2

16.0

19.5

17.6

15.3

EBITDA

6,147.0

6,463.0

10,192.0

12,964.0

11,968.0

10,841.0